Long-term effectiveness of Gliadel implant for malignant glioma and prognostic factors for survival: 3-year results of a postmarketing surveillance in Japan

BACKGROUND: Adjuvant treatment with Gliadel wafers may prolong overall survival (OS) for malignant glioma patients without increasing toxicity. In Japan, the long-term OS of these patients treated with Gliadel 7.7 mg implants has not been studied. We evaluated OS and prognostic factors that might af...

Descripción completa

Detalles Bibliográficos
Autores principales: Iuchi, Toshihiko, Inoue, Akihiro, Hirose, Yuichi, Morioka, Motohiro, Horiguchi, Keishi, Natsume, Atsushi, Arakawa, Yoshiki, Iwasaki, Koichi, Fujiki, Minoru, Kumabe, Toshihiro, Sakata, Yukinori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807118/
https://www.ncbi.nlm.nih.gov/pubmed/35118382
http://dx.doi.org/10.1093/noajnl/vdab189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807118/
https://www.ncbi.nlm.nih.gov/pubmed/35118382
http://dx.doi.org/10.1093/noajnl/vdab189

Ejemplares similares